Exact Mass: 540.302
Exact Mass Matches: 540.302
Found 224 metabolites which its exact mass value is equals to given mass value 540.302
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ciclesonide
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ciclesonide
Ciclesonide is only found in individuals that have used or taken this drug. It is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.Glucocorticoids such as ciclesonide can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Ciclesonide reduces inflammatory reaction by limiting the capillary dilatation and permeability of the vascular structures. These compounds restrict the accumulation of polymorphonuclear leukocytes and macrophages and reduce the release of vasoactive kinins. Recent research suggests that corticosteroids may inhibit the release of arachidonic acid from phospholipids, thereby reducing the formation of prostaglandins. Ciclesonide is a glucocorticoid receptor agonist. On binding, the corticoreceptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing an increase or decrease in expression of specific target genes, including suppression of IL2 (interleukin 2) expression.
(1R*,2R*,3E,7R*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,8(17)-dien-2,7,9,16,18-pentol
11-Cinnamoyl,12-Ac- Condurangamine B|condurangogenin C
3-O-(2E ,4E-Decadienoyl)-20-O-acetylingenol
6beta-acetoxy-8,13-epoxy-labd-14-en-11-one-1alpha-O-beta-glucopyranoside|forskoditerpenoside E
20-O-acetyl-[5-O-(2E,4Z)-decadienoyl]-ingenol|5-O-(2E,4Z-decadienoyl)-20-O-acetylingenol
(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-8,9-epoxydolabell-3-en-2,7,16,18-tetrol
16-acetoxy-22alpha-hydroxy-29-nor-24-methyl-6,7-epoxycycloart-1,24(24a)-dien-3,23-dion-3,4-lactone|6,7-epoxyneomacrolactone
ethyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate
(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyl-8,9-epoxydolabell-3-en-2,7,16,18-tetrol
(1R*,2R*,3E,7R*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,8(17)-dien-2,7,9,16,18-pentol
1,3,7-tri-O-acetyl-14,15-deoxyhavanensin|14,15-deoxyhavanensin triacetate
12b-O-[octa-2Z,4E-dienoyl]-13_-isobutyroyloxy-4b-deoxyphorbol
12-O-[octa-2Z,4E-dienoyl]-13-isobutyroyloxy-4-deoxyphorbol
Glu His Lys Lys
Glu Lys His Lys
Glu Lys Lys His
Phe Ile Val Tyr
Phe Ile Tyr Val
Phe Leu Val Tyr
Phe Leu Tyr Val
Phe Val Ile Tyr
Phe Val Leu Tyr
Phe Val Tyr Ile
Phe Val Tyr Leu
Phe Tyr Ile Val
Phe Tyr Leu Val
Phe Tyr Val Ile
Phe Tyr Val Leu
His Glu Lys Lys
His Lys Glu Lys
His Lys Lys Glu
Ile Phe Val Tyr
Ile Phe Tyr Val
Ile Val Phe Tyr
Ile Val Tyr Phe
Ile Tyr Phe Val
Ile Tyr Val Phe
Lys Glu His Lys
Lys Glu Lys His
Lys His Glu Lys
Lys His Lys Glu
Lys Lys Glu His
Lys Lys His Glu
Leu Phe Val Tyr
Leu Phe Tyr Val
Leu Val Phe Tyr
Leu Val Tyr Phe
Leu Tyr Phe Val
Leu Tyr Val Phe
Val Phe Ile Tyr
Val Phe Leu Tyr
Val Phe Tyr Ile
Val Phe Tyr Leu
Val Ile Phe Tyr
Val Ile Tyr Phe
Val Leu Phe Tyr
Val Leu Tyr Phe
Val Tyr Phe Ile
Val Tyr Phe Leu
Val Tyr Ile Phe
Val Tyr Leu Phe
Tyr Phe Ile Val
Tyr Phe Leu Val
Tyr Phe Val Ile
Tyr Phe Val Leu
Tyr Ile Phe Val
Tyr Ile Val Phe
Tyr Leu Phe Val
Tyr Leu Val Phe
Tyr Val Phe Ile
Tyr Val Phe Leu
Tyr Val Ile Phe
Tyr Val Leu Phe
Forskoditerpenoside E
A diterpene glycoside that is labd-14-en-11-one substituted by beta-acetoxy group at position 6, an epoxy group between positions 8 and 13 and a beta-D-glucopyranosyloxy group at position 1 (the 1alpha stereoisomer). Isolated from the whole plant of Coleus forskohlii, it shows relaxative effects on isolated guinea pig tracheal spirals in vitro.
8-[1-[4-(Dimethylamino)phenyl]-3-(3-methyl-1-piperidinyl)propyl]-5,7-dimethoxy-4-phenyl-1-benzopyran-2-one
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea
1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea
1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] hexadecanoate
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptadecanoate
[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] pentadecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tetradecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] undecanoate
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tridecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] decanoate
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tetradecanoate
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentadecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tridecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] undecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexadecanoate
(3s)-5-{[(1r,3as,4s,9r,11r,12as)-1-[2-(acetyloxy)propan-2-yl]-4,9,11-trihydroxy-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
(3s)-5-{[(1r,3as,4s,9r,11r,12as)-4-(acetyloxy)-9,11-dihydroxy-1-(2-hydroxypropan-2-yl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
2-{3-[1-(3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-3a,9b-dimethyl-6'-oxo-1,2,3,4,7,8-hexahydrospiro[cyclopenta[a]naphthalene-6,3'-oxan]-7-yl}propan-2-yl acetate
{7,7,12,16-tetramethyl-15-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5-oxo-6,19-dioxapentacyclo[9.8.0.0¹,¹⁸.0²,⁸.0¹²,¹⁶]nonadec-10-en-2-yl}methyl acetate
2-{[(2s,3r)-2-{[(2r)-2-[(2s)-2-amino-n,4-dimethylpentanamido]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-3-hydroxybenzoic acid
{15-[1-(3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-7,7,12,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-2-yl}methyl acetate
5-{[11-(acetyloxy)-6-hydroxy-15-(2-hydroxypropan-2-yl)-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
5-{[4-(acetyloxy)-9,11-dihydroxy-1-(2-hydroxypropan-2-yl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
(3s)-5-{[(1s,3r,5r,6r,9z,11s,12s,15r)-11-(acetyloxy)-6-hydroxy-15-(2-hydroxypropan-2-yl)-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid
5-({1-[2-(acetyloxy)propan-2-yl]-4,9,11-trihydroxy-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl}methoxy)-3-hydroxy-3-methyl-5-oxopentanoic acid
(2s,4s,7r,8s,9s,12r,13r,16r,17s,18r)-16-(acetyloxy)-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid
(1s,4s,5s,6r,9s,10r,12r,14r)-7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl (2z,4e)-deca-2,4-dienoate
(1r,3br,4r,5as,7r,9s,9as,9br,11as)-7,9-bis(acetyloxy)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
5-({15-[2-(acetyloxy)propan-2-yl]-6,11-dihydroxy-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl}methoxy)-3-hydroxy-3-methyl-5-oxopentanoic acid
2,3-bis(2h-1,3-benzodioxol-5-ylmethyl)-4-hydroxybutyl dodecanoate
3-o-(2' e,4' e-decadienoyl)-20-o-acetylingenol
{"Ingredient_id": "HBIN008996","Ingredient_name": "3-o-(2' e,4' e-decadienoyl)-20-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14914","TCMID_id": "4819","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102004598","DrugBank_id": "NA"}
3-o-(2' e,4'z-decadienoyl)-20-o-acetylingenol
{"Ingredient_id": "HBIN008999","Ingredient_name": "3-o-(2' e,4'z-decadienoyl)-20-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14916","TCMID_id": "4821","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102004599","DrugBank_id": "NA"}
3-o-(2' e,4'z-decadienoyl)-5-o-acetylingenol
{"Ingredient_id": "HBIN009000","Ingredient_name": "3-o-(2' e,4'z-decadienoyl)-5-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)OC(=O)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14915","TCMID_id": "4820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bisacutifolone a
{"Ingredient_id": "HBIN018595","Ingredient_name": "bisacutifolone a","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CC1CCC2(C1(C(=O)C=C(C2C)C3CCC(C4=C3C(=O)C5(C(CCC5(C4C)C)C)C(=O)OC)O)C(=O)OC)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2429","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10506624","DrugBank_id": "NA"}
bisacutifolone b
{"Ingredient_id": "HBIN018598","Ingredient_name": "bisacutifolone b","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CC1CCC2(C1(C(=O)C=C(C2C)C3CCC(C4=C3C(=O)C5(C(CCC5(C4C)C)C)C(=O)OC)O)C(=O)OC)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2432","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10626281","DrugBank_id": "NA"}